Brian Gerstenberger

Biography

Brian Gerstenberger has ten years experience as a medicinal chemistry in the design and synthesis of drug molecules for immunological, inflammation, epigenetic, and antibacterial indications at Pfizer R&D. He obtained his undergraduate degree at Siena College in New York before moving to University of California at Santa Cruz to gain a Ph.D. During his research career he has author on over twenty research papers and patents. He has made contributions to nomination of clinical candidates including a compounds entering Phase I and II clinical trials. He has also contributed in the Structural Genomic Consortium/Pfizer collaboration leading to the discovery and disclosure a number of tool compounds including PFI-2 for SETD7, PFI-3 for SMARCA2/4 and PFI-4 for BRPF1.

Research Interest

 microbiology